Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations ...

Los Angeles Times readers give their thoughts on Bill Plaschke's poignant column on Parkinson's disease, the Dodgers and the ...

Researchers have discovered how a surface protein on brain cells, called Aplp1, can play a role in spreading material ...

If you bought a Freihofer's product over the last two months, you may have helped raise more than $18,000 to benefit the ...

For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while ...

Discover how Parkinson's disease begins in the gut, not the brain. Learn the early digestive warning signs that appear years ...

A large longitudinal study found that pesticide exposure and caffeinated soda intake were linked to more severe motor ...

Parkinson's disease is a progressive and common neurodegenerative condition, typically characterized by involuntary shaking, ...

Roche entered into a Licensing, Development, and Commercialisation agreement with Prothena in December 2013 to develop and ...

Jefferies analysts said on Tuesday that Ventyx could leverage its mid-stage data for VTX3232 to position the oral drug candidate as a treatment for other neurodegenerative diseases, including ...

Description: Changes in gut and oral bacteria are linked to worsening cognitive symptoms in people with Parkinson's disease.

Basel: Roche has announced its decision to proceed with Phase III development of prasinezumab, an investigational ...